Israel Active

Researchers at the Hebrew University of Jerusalem have developed a cellulose-based gel that dries on the skin and blocks mosquitoes from detecting human scents. Even those mosquitoes that get through are unable to lay eggs due to the effects of the gel.

2% of the millions of knee replacements each year result in untreatable infections due to the bacteria protecting themselves with an impenetrable biofilm. Israel’s Dimoveo Medical has developed a process using nanoparticles to “sandblast” the biofilm and allow antibiotics to kill the bacteria.

Yaron Segal’s son Lear was born with familial dysautonomia (Riley-Day syndrome). Yaron established the startup BrainQ (see previously) to search for a solution. His brainwave helmet doesn’t help Lear, but its low-intensity electromagnetic field is curing many stroke patients.

Israel’s AISAP (see previously) has received US FDA approval for its CARDIO point-of-care ultrasound (POCUS) platform. It allows accurate diagnosis of up to 90% of the most common cardiac parameters within minutes, either in an incident or during treatment.

Researchers at Israel’s Technion Institute have used new materials to enhance Magnetic Resonance Imaging signals by up to 4 times and preserve the signal for 10 mins (previously only 1 min). This gives doctors time to track metabolites in the tissues – important clinical markers for diseases including cancer.

Einat had already brought 10 children into the world.  But her 11th was the first to be born underground. The maternity ward at Israel’s Rambam Medical Center had been relocated to the level minus 3 car park. Nevertheless, a healthy baby was born and all 10 siblings came to visit mother and newborn.

Remember when MDA began the medical training of 1,000 Wolt delivery drivers. Well Ilan had already been trained, so when he was called while delivering pizza, he knew what to do.  He didn’t deliver pizza, he delivered a baby instead.  Meanwhile, the ambulance team ate the pizza.

Tel Aviv University researchers have developed a method to detect protein aggregation in cells that are the hallmark of Parkinson’s disease. With super-resolution microscopy, they analyzed skin cells on patients with gene mutations on specific cells .

Israeli startup Dermab.io is developing personalized biologic therapies for people suffering from chronic and autoimmune diseases. It aims to produce tailored, precision treatments, based purely on individual biomarkers gathered in a simple, non-invasive skin swab.

A 12-months Phase 2b trial of PrimeC from Israel’s NeuroSense (see previously) showed a 73% improvement over placebo in slowing ALS progression among patients. It also achieved a 63% increase in survival rates.